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Abstract  19 
The IncX family of plasmids has recently been expanded to include at least four subtypes, IncX1-IncX4. The 20 
revised classification provides an opportunity for improving our understanding of the sequence diversity of the 21 
IncX plasmids and the resistance genes they carried. We described the complete nucleotide sequence of a novel 22 
IncX3 plasmid, pKPC-NY79 (42,447 bp) from a sequence type 258 Klebsiella pneumoniae strain that was 23 
isolated from a patient who was hospitalized in New York, United States. In pKPC-NY79, the plasmid scaffold 24 
and genetic load region were highly similar to homologous regions in pIncX-SHV (IncX3, JN247852) and the 25 
blaKPC carrying pKpQIL (IncFIIk, GU595196), respectively, indicating that it has possibly arisen through 26 
recombination of plasmids. The blaKPC-2 gene, as part of a transposon Tn4401a, was found within the genetic 27 
load region. The backbone of pKPC-NY79 differs from pIncX-SHV by a deletion involving the gene tandem 28 
hns-topB (encoding H-NS protein and topoisomerase III, respectively) and a putative ATPase gene. 29 
Unexpectedly, the impact of the hns-topB deletion on host fitness and plasmid stability was found to be small. In 30 
conclusion, the findings contribute to a better understanding of the plasmid platforms carrying blaKPC and of 31 
variations in the backbone of the IncX3 plasmids.  32 
 33 
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 36 
Introduction 37 
In Enterobacteriaceae, the most frequent class A carbapenmases are the KPC enzymes [26]. The first 38 
KPC-producing isolate was identified in a Klebsiella pneumoniae strain from North Carolina, USA in 1996. 39 
Since then, carbapenem-resistant, KPC-producing isolates have increased in frequency, species distribution and 40 
geographical distribution [3,19]. The spread of KPC involves clones, plasmids and transposons. Globally, 41 
KPC-producing K. pneumoniae isolates were often found to be sequence type (ST) 258 or its variant ST11 42 
[22,26]. These KPC-producing isolates carry plasmids which encode the blaKPC genes as part of a transposon 43 
Tn4401 or its variants [18,22]. On the basis of sequence deletions upstream of blaKPC, five isoforms of Tn4401a 44 
to Tn4401e have been identified which were associated with different levels of blaKPC gene expression [18]. In 45 
China, a variant of Tn4401, harboring ISKpn8, was reported to carry blaKPC genes in most isolates [22]. While at 46 
least 13 different alleles have been reported, KPC-2 and KPC-3 occur most widely [8,26]. The blaKPC genes 47 
have been reported on plasmids with narrow (IncFIIk, ColE) and broad (IncN, IncL/M and IncA/C) host range or 48 
on untypable plasmids. The first blaKPC-carrying plasmids to be completely sequenced were p9 (IncN, 49 
FJ223607), p12 (IncN, FJ223605) and p15S (ColE, FJ223606) [9]. The other plasmids that have been 50 
completely sequenced were pKP048 (IncFIIk, FJ628167), pSLMT (IncFIIk, HQ589350), pKpQIL (IncFIIk, 51 
GU595196), pKpQIL-IT (IncFIIk, JN233705), pKPHS2 (IncFIIk, CP003224) and pKPN101-IT (IncFIIk, 52 
JX283456).  53 
The IncX plasmids are narrow host range plasmids of Enterobacteriaceae. Such plasmids have most 54 
often been reported in E. coli, Salmonella spp. and Klebseilla spp [15,20]. They are known to encode type IV 55 
secretion system (T4SS), enabling their own conjugative transfer, and to carry genes encoding biofilm formation 56 
and antimicrobial resistance. PCR-based replicon typing (PBRT) procedures demonstrated that the IncX 57 
plasmids occur infrequently in 1% or less of the Escherichia coli populations [2,15]. Recently, comparative 58 
analysis of completely sequenced IncX plasmids demonstrated that the IncX plasmids could be subdivided into 59 
four subgroups, IncX1 to IncX4, and the prototype plasmid R6K belonged to the IncX2 subgroup [14]. The 60 
basic core structures of the IncX plasmids include sequences encoding replication, partitioning, T4SS, 61 
transcriptional activator and putative DNA transfer protein [14,20]. Based upon the taxC gene, a revised typing 62 
scheme was proposed and these plasmids were shown to be more prevalent than previously acknowledged [14]. 63 
In this study, we report the complete sequence of a novel IncX3 plasmid, designated pKPC-NY79 carrying 64 
blaKPC originating from a patient with epidemiological link to the United States.  65 
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 66 
Material and methods 67 
 68 
Bacterial strain 69 
In 2011, we identified a K. pneumoniae strain CRE79 carrying blaKPC-2 from a urine sample of a 71 year-old 70 
man who was repatriated from New York, United States, where he had been hospitalized for intracranial 71 
hemorrhage. The organism was identified by the Vitek II (bioMérieux SA, Marcy l'Etoile, France). The disc 72 
diffusion method and Etest (AB Biodisk, Solna, Sweden) were used to determine the susceptibility to antibiotics 73 
[4]. Combined disc test was used to determine the carbapenemase phenotype using EDTA or boronic acid as 74 
inhibitors [10]. 75 
 76 
Molecular studies 77 
The major carbapenemase genes (blaKPC, blaNDM, blaIMP, blaVIM and blaOXA-48) were detected by PCR using 78 
previously described primers (Supplementary file, Table S1) [10,13]. The multilocus sequence type (MLST) of 79 
the strain was determined using the Pasteur Institute scheme [6]. In brief, internal portions of seven 80 
housekeeping genes were amplified and sequenced: rpoB (beta-subunit of RNA polymerase), gapA 81 
(glyceraldehyde 3-phosphate dehydrogenase), mdh (malate dehydrogenase), pgi (phosphoglucose isomerase), 82 
phoE (phosphorine E), infB (translation initiation factor) and tonB (periplasmic energy transducer). A different 83 
allele number was given to each distinct sequence within a locus, and a distinct sequence type (ST) number was 84 
attributed to each distinct allelic profile. Allele sequences and STs are available on the web site at 85 
http:/www.pasteur.fr/mlst. The transferability of blaKPC was tested by filter mating using Escherichia coli J53 86 
(azide-resistant) as the recipient [13]. Transconjugants were selected on MacConkey medium containing sodium 87 
azide (100 µg/ml) and meropenem (0.5 µg/ml).  88 
Plasmid DNA was extracted with QIAGEN Large Construct kit (Qiagen, Hilden, Germany). 89 
Subsequently, the plasmids were converted to the linear forms by incubation with Aspergillus oryzae S1 90 
nuclease (Sigma Chemical Cp., St Louis, MO, USA) and were sized by pulsed-field gel electrophoresis [12]. 91 
The complete sequence of the plasmid pKPC-NY79 carrying blaKPC in a J53 transconjugant (originating from K. 92 
pneumoniae strain CRE79) was obtained by using the 454 GS FLX system (Roche, USA) according to the 93 
manufacturer’s instruction. The library yielded a total of 64,798 reads with average read length of 500 bp. The 94 
reads were assembled by the GS de novo Assembler (version 2.6) into two contigs. The gaps were closed by 95 
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PCR and Sanger sequencing. The plasmid was annotated by RAST Server and each predicted open reading 96 
frames (ORFs) was further blast against the NCBI non-redundant protein database using BLASTP [1,13]. 97 
Additional bioinformatics analyses were conducted as previously described [12,13].  98 
 99 
Plasmid stability and fitness cost 100 
Stability tests were conducted as described previously [23]. Three ul of an overnight growth of the bacteria in 101 
Luria-Beranti (LB) broth were inoculated into 3 ml of a fresh LB broth and incubated for 12 hours at 37 oC 102 
(time zero). The above process was repeated every 12-hourly (equivalent to 10 generations each). At time zero 103 
and after passage in the absence of antibiotic for 50, 100, 150 and 200 generations, a sample of the culture was 104 
diluted and spread onto LB plate. One hundred colonies were picked and replica plated onto a pair of plain and 105 
antibiotic-containing (0.5 µg/ml meropenem) LB plates. Plasmid stability was determined through the 106 
percentage of colonial growth on the antibiotic-containing plates. Testing was conducted on two separate 107 
occasions.  108 
Two growth parameters including the lag phase and the doubling time in the exponential phase were 109 
used to assess the fitness cost associated with the introduction of pKPC-NY79. The test strains were E. coli J53 110 
and a J53 transconjugant with the plasmid (J53/pKPC-NY79). Bacteria were cultured in LB broth at 37 oC with 111 
shaking. Growth was monitored every 15 minutes by the optical density until the readings reach a plateau. A 112 
growth curve of optical density versus time was plotted and the doubling time calculated as previously described 113 
[5]. The lag phase was obtained by extrapolating the tangent at the exponential part of the growth curve back to 114 
the inoculum level [24]. This experiment was carried out on three separate occasions.  115 
 116 
Results and discussion 117 
 118 
Phenotypic and genotypic characteristics of the bacterial strain 119 
The K. pneumoniae strain CRE79 was resistant to all β-lactams, including imipenem (>32 µg/ml), ertapenem 120 
(>32 µg/ml), meropenem (>32 µg/ml), and multiple non-β-lactam antibiotics (amikacin, ciprofloxacin, 121 
chloramphenicol, cotrimoxazole, nitrofurantoin). It was susceptible only to gentamicin, colistin and fosfomycin 122 
(8 µg/ml). The extensively drug-resistant phenotype was consistent with those exhibited by KPC epidemic 123 
clones circulating in different countries [8,17,19].  Combined disc testing showed that carbapenem-resistance 124 
could be reversed by boronic acid but not EDTA. MLST identified CRE79 as ST 258, which is a major lineage 125 
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associated with dissemination of blaKPC in many countries [3,16]. PCR assays showed that it was positive for 126 
blaKPC but negative for the other major carbapenemase genes (blaNDM, blaIMP, blaVIM and blaOXA-48). The blaKPC 127 
carrying plasmid was conjugatively transferred to Escherichia coli J53 at frequency of 10-6 per donor cells. In 128 
the transconjugant, resistance to β-lactam antibiotics including carbapenems was the only resistance trait 129 
transferred. Pulsed-field gel electrophoresis and S1 nuclease digestion gave a single plasmid band of ~40 kb. 130 
The complete sequence of the plasmid is presented here. 131 
 132 
Nucleotide sequence analysis of pKPC-NY79 133 
The plasmid (designated as pKPC-NY79, GenBank accession JX104759) is a 42,447 bp circular 134 
plasmid with an average GC content of 48.5% and 38 putative open reading frames (ORFs) ( Table 1). The 135 
plasmid backbone shares high sequence homology to IncX3 plasmids [8,14], exemplified by pIncX-SHV 136 
(JN247852) and pEC14_35 (JN935899) which were used as references for annotating pKPC-NY79. When this 137 
plasmid was tested by the initially described PBRT [2], the result was negative. Testing with the revised IncX 138 
typing scheme based upon the taxC genes [14] detected the plasmid as belonging to the IncX3 subgroup. Figure 139 
1 shows the backbone regions shared by pIncX-SHV and pKPC-NY79 comprise sequences encoding replication 140 
(replication initiation protein, pir; replication accessory protein, bis), partitioning (parA), conjugation/type IV 141 
secretion system (T4SS, with 11 genes, pilX1 to pilX11), transcriptional activator (actX) and putative DNA 142 
transfer proteins (taxA and taxC). However, pKPC-NY79 was modified by a deletion involving the putative 143 
plasmid stability tandem genes hns–topB (encoding a putative DNA-binding protein and a putative type III 144 
topoisomerase, respectively) and a gene encoding ATPase (atpase), as comparing with pIncX-SHV. In 145 
pKPC-NY79, the genetic load region between the resolvase, res gene and parB is 16.4 kb in length, including 146 
the blaKPC-2 carrying Tn4401a transposon and an upstream 8.2 kb region with three transposases (IS26-tnpA, 147 
Tn3-tnpA and ISAs12-tnpA), one resolvase (Tn3-tnpR) and a truncated umuD which putatively encodes for an 148 
ultraviolet repair protein. The tnpR gene in the right extremity of Tn4401a was truncated (Figure 1). Of note, the 149 
genetic load region from position 6441 to 21387 (JX104759) is almost identical (query coverage 100%, identity 150 
99.9%) to the same gene array in the epidemic blaKPC-3 carrying plasmid pKpQIL (GU595196, IncFIIk) which 151 
was associated with the spread of blaKPC in the United States, Israel and Italy [8,17,19]. The finding suggested 152 
that pKPC-NY79 might have evolved from recombination events involving IncX3/pIncX-SHV-like and 153 
IncFIIk/pKpQIL-like plasmid ancestors. In this regard, it is interesting that two such plasmids 154 
(IncX3/pIncX-SHV and IncFIIk-FIBk/pKpQIL-IT) were found in the K. pneumoniae strain 55873 [8]. The two 155 
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blaKPC alleles that were found in the two highly homologous regions in pKPC-NY79 (blaKPC-2, His271, codon 156 
CAC) and pKpQIL (blaKPC-3 Tyr271, codon TAC) could possibly arise through nucleotide substitution [27]. 157 
Similar phenomena have been reported for blaCTX-M alleles carried on highly similar plasmid IncFII 158 
(blaCTX-M-14/24), IncN (blaCTX-M-1/32) and IncL/M (blaCTX-M-3/15) platforms [12,21].  159 
 160 
Plasmid stability of pKPC-NY79 and its effect on bacterial host fitness 161 
Previous studies have demonstrated that plasmid-encoded H-NS proteins such as sfh have a “stealth” function 162 
that allow the plasmids to be transferred to the new bacterial hosts with minimal effects on their fitness [7]. 163 
Given the deletion of the tandem genes hns–topB in pKPC-NY79, we assessed the impact of introducing the 164 
plasmid into strain J53 and the stability of the plasmid in absence of antibiotics. The findings showed that 165 
introduction of the plasmid significantly increased the lag phase and doubling time of the host strain but the 166 
magnitude of the effects were small (Table 2). Stability of pKPC-NY79 with the hns–topB deletion could be 167 
maintained at 100% over 50 generations of multiplication in the absence of antibiotics. However, a drastic loss 168 
of pKPC-NY79 was observed after 100 generations of multiplication, with 75% and 28.5% retaining the 169 
plasmid at 150 and 200 generations respectively. As reviewed recently, plasmid-encoded hns-like genes occur in 170 
a wide range of different plasmids [25]. Unlike previous studies which demonstrated a major adverse effect on 171 
fitness [7], our results showed that this IncX3 plasmid variant with hns deletion only has a modest effect on the 172 
host and plasmid stability was only affected after prolonged propagation in the absence of antibiotics. The 173 
discordant observations could possibly be related to host species (Salmonella spp. vs. E. coli), plasmid size (42 174 
kb vs. >100 kb) and host adaptive mutations [23,25]. 175 
  176 
In conclusion, we hereby described the complete sequence of a blaKPC-2-carrying IncX3 plasmid with some 177 
unique features in the backbone sequences. The findings contribute to a better understanding of the replicon 178 
types of plasmids involved in the dissemination of the blaKPC genes. The natural distribution of the IncX3 group 179 
of plasmids and the roles that they play in the dissemination of emerging resistance genes remains to be 180 
elucidated [11]. 181 
 182 
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Fig. 1 Comparative analysis of linear plasmid maps for two plasmids, pIncX-SHV and pKPC-NY79 and a partial sequence in pKpQIL. The function blocks of the plasmids 187 
are indicated above the linear maps. The lengths of the ORFs are drawn in proportion to the size of the ORFs. Homologous ORFs in the plasmid maps are represented in the 188 
same colour. Mobile elements are labelled in yellow. The promoters, P1 and P2 of blaKPC gene are identified and annotated as described previously [18]. The accession 189 
numbers were: pIncX-SHV (JN247852); pKPC-NY79 (JX104759) and pKpQIL (GU595196). 190 
 191 
192 
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Table 1  Open reading frames identified in pKPC-NY79 193 
ORF 
number 
Gene name (alternative 
name) 
Position in 
JX104759 
Strand Size 
(bp) 
Function 
1.  pir (repB) 1-1014 + 1014 replication initiator protein 
2.  
bis 
1023-1466 + 444 conserved hypothetical 
protein   
3.  
taxD 
1585-2007 + 423 DNA distortion 
polypeptide 
4.  hyp 2659-2348 − 312 hypothetical protein 
5.  hyp 3176-2865 − 312 hypothetical protein 
6.  parA 3911-3249 − 663 plasmid partition protein 
7.  res 4274-4954 + 681 resolvase 
8.  ΔumuD 5283-5639 + 357 truncated DNA polymerase 
9.  tnpA (IS26) 6389-5673 − 717 transposase of IS26 
10.  tnpA (Tn3) 6450-9347 + 2898 transposase of Tn3 
11.  tnpR (Tn3) 9415-10056 + 642 resolvase of Tn3 
12.  hyp 11581-11222 − 360 hypothetical protein 
13.  tnpA (ISAs12) 12085-13269 + 1185 transposase of ISAs12 
14.  tnpA (ISkpn6) 13546-14865 + 1320 transposase of ISkpn6 
15.  blaKPC-2 15996-15115 − 882 Carbapenemase 
16.  istB (ISkpn7) 17063-16284 − 780 transposase of ISkpn7 
17.  istA (ISkpn7) 18085-17060 − 1026 transposase of ISkpn7 
18.  tnpA (Tn4401a) 21221-18192 − 3030 transposase of Tn4401a 
19.  
ΔtnpR (Tn4401a) 
21330-21388 + 59 truncated resolvase of 
Tn4401a 
20.  parB 21966-21454 − 513 plasmid partition protein 
21.  hyp 22271-21945 − 327 hypothetical protein 
22.  kikA 22671-22357 − 315 killer family protein  
23.  trbM 23151-22759 − 393 VirB/Tra/Trw family 
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protein  
24.  taxB 24983-23148 − 1836 conjugal transfer protein 
25.  pilX11  26020-24986 − 1035 conjugal transfer protein 
26.  pilX10    27181-26216 − 966 conjugal transfer protein 
27.  pilX9 28356-27427 − 930 conjugal transfer protein 
28.  pilX8 29090-28362 − 729 conjugal transfer protein 
29.  pilX6 30340-29285 − 1056 conjugal transfer protein 
30.  pilX5 31389-30619 − 771 conjugal transfer protein 
31.  pilX3-pilX4 34152-31399 − 2754 conjugal transfer protein 
32.  pilX2 34485-34177 − 309 conjugal transfer protein 
33.  pilX1 35095-34451 − 645 conjugal transfer protein 
34.  
actX 
35978-35328 − 651 Transcription 
anti-terminator 
35.  taxC 37350-36190 − 1161 DNA transfer relaxase 
36.  
taxA 
37967-37353 − 615 DNA transfer auxiliary 
protein 
37.  hyp 37949-38554 + 606 hypothetical protein 
38.  hyp 40225-39674 − 552 hypothetical protein 
39.  hyp 41161-40580 − 582 hypothetical protein 
 194 
 195 
 196 
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Table 2. Effect of pKPC-NY79 on bacterial growth parameters 
 Mean time (minutes) ± standard deviation P value 
 J53 J53, pKPC-NY79  
Lag phase 134.6 ± 0.2 144.1 ± 0.6 <0.001 
Doubling time 25.4 ± 0.1 26.4 ± 0.4 0.02 
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